Y-Intercept (HK)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,527
| Closed | -$241K | – | 1593 |
|
|
2025
Q1 | $241K | Sell |
14,527
-18,378
| -56% | -$305K | 0.02% | 983 |
|
|
2024
Q4 | $604K | Sell |
32,905
-17,639
| -35% | -$324K | 0.04% | 638 |
|
|
2024
Q3 | $777K | Sell |
50,544
-39,245
| -44% | -$604K | 0.05% | 554 |
|
|
2024
Q2 | $1.46M | Sell |
89,789
-51,647
| -37% | -$839K | 0.08% | 347 |
|
|
2024
Q1 | $2.62M | Buy |
+141,436
| New | +$2.62M | 0.2% | 115 |
|
|
2023
Q4 | – | Sell |
-68,887
| Closed | -$1.44M | – | 1178 |
|
|
2023
Q3 | $1.44M | Buy |
68,887
+48,928
| +245% | +$1.02M | 0.14% | 216 |
|
|
2023
Q2 | $478K | Sell |
19,959
-8,190
| -29% | -$196K | 0.05% | 578 |
|
|
2023
Q1 | $530K | Buy |
28,149
+4,286
| +18% | +$80.7K | 0.06% | 497 |
|
|
2022
Q4 | $380K | Sell |
23,863
-5,278
| -18% | -$84K | 0.06% | 546 |
|
|
2022
Q3 | $477K | Buy |
29,141
+15,071
| +107% | +$247K | 0.05% | 556 |
|
|
2022
Q2 | $198K | Buy |
14,070
+4,169
| +42% | +$58.7K | 0.03% | 686 |
|
|
2022
Q1 | $240K | Sell |
9,901
-98
| -1% | -$2.38K | 0.05% | 538 |
|
|
2021
Q4 | $233K | Buy |
+9,999
| New | +$233K | 0.06% | 470 |
|